Merck & Co. Inc. buy Guggenheim
Start price
17.04.25
/
50%
€68.70
Target price
17.04.26
€101.20
Performance (%)
52.55%
Price
27.02.26
€104.80
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Merck & Co. Inc. has seen massive gains of 52.55%. This prediction currently runs until 17.04.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 0.963% | 0.963% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $115.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.60
06.02.26
06.02.26
€118.75
06.02.27
06.02.27
1.16%
27.02.26
27.02.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.40
12.02.25
12.02.25
€110.77
12.02.26
12.02.26
20.14%
13.02.26
13.02.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.60
06.11.24
06.11.24
€121.00
06.11.25
06.11.25
-21.04%
07.11.25
07.11.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24